Literature DB >> 11159696

The critical role of adenosine and guanosine in the affinity of dinucleoside polyphosphates to P(2X)-receptors in the isolated perfused rat kidney.

M van der Giet1, T Westhoff, O Cinkilic, J Jankowski, H Schlüter, W Zidek, M Tepel.   

Abstract

1. The activation of P(2x)-receptors in the rat renal vasculature by dinucleoside polyphosphates with variable phosphate group chain length (Xp(n)X; X=Adenin (A) /Guanin (G), n=4 - 6) was studied by measuring their effects on perfusion pressure of the isolated perfused rat kidney at constant flow in an open circuit. 2. Like Ap(4)A, Ap(5)A and Ap(6)A the dinucleoside polyphosphates Ap(4)G, Ap(5)G and Ap(6)G exerted a vasoconstriction which could be blocked by suramin and pyridoxal-phosphate-6-azophenyl-2; 4-disulphonic acid (PPADS). 3. Gp(4)G, Gp(5)G and Gp(6)G showed only very weak vasoconstriction at high doses. 4. Ap(6)A and alpha, beta-meATP could not be blocked by the selective P(2x1)-receptor antagonisten NF023 (30 microM), whereas Ap(4)A, Ap(4)G, Ap(5)A, Ap(5)G and Ap(6)G were partially blocked by NF023. 5. Inhibition of endothelial NO-synthase by N(omega)-nitro-L-arginine methyl ester (L-NAME) did not affect vasoconstrictions induced by dinucleosidepolyphosphates. 6. P(2x)-receptor can only be activated if at least one adenosine moiety is present in the molecule. 7. Ap(n)G show a weaker vasoconstrictive action than corresponding Ap(n)A, concluding that two adenosine moieties enhance the P(2x)-receptor binding and activation. 8. Xp(n)X containing five phosphate groups show the most pronounced vasoconstrictive effect whereas four phosphate groups show the less effect, therefore the number of phosphate groups critically changes receptor affinity. 9. Additional experiments using permanent perfusion with alpha, beta-methylene ATP (alpha,beta-meATP) and the selective P(2x1)-receptor antagonist NF023 showed that the newly discovered human dinucleoside polyphosphates activated the vascular P(2x1)-receptor and an recently identified new P(2x)-receptor subtype. 10. The differential effects of dinucleoside polyphosphates allow a fine tuning of local perfusion via composition of Xp(n)Xs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159696      PMCID: PMC1572568          DOI: 10.1038/sj.bjp.0703817

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney.

Authors:  M van der Giet; O Cinkilic; J Jankowski; M Tepel; W Zidek; H Schlüter
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  A P2X purinoceptor cDNA conferring a novel pharmacological profile.

Authors:  X Bo; Y Zhang; M Nassar; G Burnstock; R Schoepfer
Journal:  FEBS Lett       Date:  1995-11-13       Impact factor: 4.124

3.  Regulation of rat mesangial cell growth by diadenosine phosphates.

Authors:  S Heidenreich; M Tepel; H Schlüter; B Harrach; W Zidek
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Effects of diadenosine polyphosphates (Ap(n)As) and adenosine polyphospho guanosines (Ap(n)Gs) on rat mesenteric artery P2X receptor ion channels.

Authors:  C J Lewis; D P Gitterman; H Schlüter; R J Evans
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

5.  Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).

Authors:  R J Evans; C Lewis; G Buell; S Valera; R A North; A Surprenant
Journal:  Mol Pharmacol       Date:  1995-08       Impact factor: 4.436

6.  Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney.

Authors:  M Eltze; B Ullrich
Journal:  Eur J Pharmacol       Date:  1996-06-13       Impact factor: 4.432

7.  Effect of plasma from patients with essential hypertension on vascular resistance in the isolated perfused rat kidney.

Authors:  J Bachmann; H Schlüter; W Storkebaum; H Witzel; F Wessels; W Zidek
Journal:  Clin Sci (Lond)       Date:  1991-01       Impact factor: 6.124

8.  Pharmacological characterization of the renovascular P2 purinergic receptors.

Authors:  P C Churchill; V R Ellis
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

9.  Diadenosine phosphates and the physiological control of blood pressure.

Authors:  H Schlüter; E Offers; G Brüggemann; M van der Giet; M Tepel; E Nordhoff; M Karas; C Spieker; H Witzel; W Zidek
Journal:  Nature       Date:  1994-01-13       Impact factor: 49.962

10.  Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries.

Authors:  V Ralevic; C H Hoyle; G Burnstock
Journal:  J Physiol       Date:  1995-03-15       Impact factor: 5.182

View more
  3 in total

Review 1.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

2.  Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney.

Authors:  Markus Tölle; Mirjam Schuchardt; Annette Wiedon; Tao Huang; Lars Klöckel; Joachim Jankowski; Vera Jankowski; Walter Zidek; Markus van der Giet
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  The role of uridine adenosine tetraphosphate in the vascular system.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Adv Pharmacol Sci       Date:  2011-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.